ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting

Newly Launched Q Guidance System with Spine Guidance Software Receives 2022 Spine Technology Award

Stryker (NYSE: SYK), one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society (NASS) annual meeting in Chicago, Oct. 12–15 (booth #4211).

“Our expanding portfolio of differentiated spinal procedural innovations demonstrates our commitment to bringing state-of-the-art technology to surgeons and their patients,” said Robbie Robinson, President of the Spine division, Stryker. “This has been an exciting year with several new products launched, signifying the continued growth of our Spine business. We are thrilled to reconnect with current and make the acquaintance of future customers as well as showcase our newest additions at NASS.”

The Company will highlight legacy solutions along with several newly launched products, which include:

  • Q Guidance System with Spine Guidance Software combines a redesigned, fourth generation FP8000 camera with an intuitive user interface and sophisticated algorithms to deliver more surgical spine planning and navigation capability than ever before. The Q Guidance System is the hub of Stryker’s fully integrated ecosystem, driving more value for its customers. With a robust product pipeline in place that will include Cranial Guidance Software*, Stryker is positioned to provide a well-rounded, end-to-end guidance platform for its surgeon customers. The Company is also currently developing the Mako robotic technology for spinal application that is intended to integrate with its navigation technology**. During the meeting, the Q Guidance System with Spine Guidance Software will be awarded the 2022 Best Technology in Spine by Orthopedics This Week, which recognizes excellence in innovation for the year’s best new technologies, along with their engineering teams and inventors.
  • Monterey® AL Interbody System is a stand-alone interbody fusion device designed for anterior lumbar interbody fusion. The System is the latest cage built using Tritanium In-Growth Technology and is validated by newly presented pre-clinical data demonstrating that undifferentiated stem cells grown on Tritanium exhibited osteogenic Alkaline Phosphatase without requiring growth factor supplements.1,2
  • Bone Mill+™ features an enhanced power base, a new bone mill that can produce 46% more bone yield, 99 times faster compared to manual milling, and a new disposable cartridge for automated tissue removal that is 2.5 times faster than manual tissue removal.3
  • OmniCurve™ is a curved balloon system built on the strength of AVAflex balloon system and designed to enhance the user’s capabilities and control. Enabling a one-handed technique, it is designed to reach midline every time and offers unipedicular access with bipedicular results.4

Stryker will showcase its portfolio of spine solutions at NASS (booth #4211), including a chance to experience the technologies hands-on during a Surgical Stadium event taking place Friday, October 14, from 10:45 a.m.–12:00 p.m. in the Technical Exhibition McCormick Place, West Building, with proctors Drs. Shah Dodwad and Griffin R. Baum.

*Cranial Guidance Software has not yet received 510(k) clearance to market.

**Mako for spine applications is not available for sale.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, and Orthopaedics and Spine that help improve patient and hospital outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

References:

1. Stryker data on file; RD 62430 Tritanium hMSC osteogenic differentiation.

2. Reza, A. et al. "Randomized porous titanium impacts cell morphology and induces stem cell differentiation in vitro." Orthopaedic Research Society 5th International Spine Research Symposium, 2019, 5: 83.

3. Stryker data on file (10-minute Bone Mill+ cycle vs 10 minutes of manual soft tissue removal)

4. Stryker data on file (Based on fill volume)

CONTENT ID: QGS-MM-2_3426

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.